KEGG   PATHWAY: chx05017
Entry
chx05017                    Pathway                                
Name
Spinocerebellar ataxia - Capra hircus (goat)
Description
The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.
Class
Human Diseases; Neurodegenerative disease
Pathway map
chx05017  Spinocerebellar ataxia
chx05017

Organism
Capra hircus (goat) [GN:chx]
Gene
102184361  TRPC3; short transient receptor potential channel 3 isoform X1 [KO:K04966]
102189950  guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
102188148  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
102180505  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
102169966  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
102189653  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
102180890  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
102172114  PRKCB; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
102175984  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
102171059  GRIA1; glutamate receptor 1 isoform X3 [KO:K05197]
102168378  GRIA2; glutamate receptor 2 isoform X1 [KO:K05198]
102169266  GRIA3; glutamate receptor 3 [KO:K05199]
102168441  CACNA1A; voltage-dependent P/Q-type calcium channel subunit alpha-1A isoform X1 [KO:K04344]
102188092  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
102170858  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
102184768  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
102180146  ATXN2; ataxin-2 isoform X1 [KO:K23625]
102181918  ATXN2L; ataxin-2-like protein isoform X1 [KO:K23625]
102188805  ATXN3; ataxin-3 isoform X1 [KO:K11863] [EC:3.4.22.-]
102179229  RYR1; ryanodine receptor 1 isoform X1 [KO:K04961]
100860866  PDYN; proenkephalin-B [KO:K15840]
102181789  GRIN1; glutamate receptor ionotropic, NMDA 1 isoform X1 [KO:K05208]
102189537  GRIN2A; glutamate receptor ionotropic, NMDA 2A [KO:K05209]
108636054  GRIN2B; glutamate receptor ionotropic, NMDA 2B [KO:K05210]
102177097  GRIN2C; glutamate receptor ionotropic, NMDA 2C isoform X1 [KO:K05211]
102177187  GRIN2D; glutamate receptor ionotropic, NMDA 2D [KO:K05212]
102191614  GRIN3A; glutamate receptor ionotropic, NMDA 3A [KO:K05213]
102174657  GRIN3B; LOW QUALITY PROTEIN: glutamate receptor ionotropic, NMDA 3B [KO:K05214]
102184878  MCU; calcium uniporter protein, mitochondrial [KO:K20858]
102173290  VDAC1; voltage-dependent anion-selective channel protein 1 [KO:K05862]
102169457  VDAC2; voltage-dependent anion-selective channel protein 2 [KO:K15040]
102176666  VDAC3; voltage-dependent anion-selective channel protein 3 isoform X1 [KO:K15041]
102173075  SLC25A5; ADP/ATP translocase 2 [KO:K05863]
102178813  ADP/ATP translocase 3 [KO:K05863]
102176546  SLC25A31; ADP/ATP translocase 4 [KO:K05863]
100861351  SLC25A4; ADP/ATP translocase 1 [KO:K05863]
102187374  PPIF; peptidyl-prolyl cis-trans isomerase F, mitochondrial [KO:K09565] [EC:5.2.1.8]
106501717  cytochrome c 2 [KO:K08738]
102173997  cytochrome c [KO:K08738]
102181419  AFG3-like protein 1 isoform X1 [KO:K08956] [EC:3.4.24.-]
102179059  AFG3L2; AFG3-like protein 2 [KO:K08956] [EC:3.4.24.-]
102169446  OMA1; metalloendopeptidase OMA1, mitochondrial isoform X1 [KO:K23010] [EC:3.4.24.-]
102185118  OPA1; dynamin-like 120 kDa protein, mitochondrial isoform X1 [KO:K17079] [EC:3.6.5.5]
102179782  FGF14; fibroblast growth factor 14 isoform X1 [KO:K23920]
102179357  SPTBN2; spectrin beta chain, non-erythrocytic 2 isoform X1 [KO:K23932]
100860840  PSMA6; proteasome subunit alpha type-6 [KO:K02730] [EC:3.4.25.1]
102188113  PSMA2; proteasome subunit alpha type-2 [KO:K02726] [EC:3.4.25.1]
102184096  PSMA4; proteasome subunit alpha type-4 [KO:K02728] [EC:3.4.25.1]
102172642  PSMA7; proteasome subunit alpha type-7 isoform X1 [KO:K02731] [EC:3.4.25.1]
102187178  PSMA8; proteasome subunit alpha type-7-like isoform X1 [KO:K02731] [EC:3.4.25.1]
102186449  PSMA5; proteasome subunit alpha type-5 [KO:K02729] [EC:3.4.25.1]
102190150  PSMA1; proteasome subunit alpha type-1 [KO:K02725] [EC:3.4.25.1]
102168353  PSMA3; proteasome subunit alpha type-3 [KO:K02727] [EC:3.4.25.1]
102176996  PSMB6; proteasome subunit beta type-6 [KO:K02738] [EC:3.4.25.1]
102182415  PSMB7; proteasome subunit beta type-7 [KO:K02739] [EC:3.4.25.1]
102175796  PSMB3; proteasome subunit beta type-3 [KO:K02735] [EC:3.4.25.1]
102181749  PSMB2; proteasome subunit beta type-2 [KO:K02734] [EC:3.4.25.1]
102175024  PSMB5; proteasome subunit beta type-5 [KO:K02737] [EC:3.4.25.1]
102182039  PSMB1; proteasome subunit beta type-1 [KO:K02732] [EC:3.4.25.1]
102178323  PSMB4; proteasome subunit beta type-4 [KO:K02736] [EC:3.4.25.1]
102191015  PSMC2; 26S protease regulatory subunit 7 [KO:K03061]
102190237  PSMC1; 26S protease regulatory subunit 4 [KO:K03062]
102186623  PSMC4; 26S protease regulatory subunit 6B [KO:K03063]
102180674  PSMC6; 26S protease regulatory subunit 10B [KO:K03064]
102187246  PSMC3; 26S protease regulatory subunit 6A [KO:K03065]
102176071  PSMC5; 26S protease regulatory subunit 8 [KO:K03066]
102183547  PSMD2; 26S proteasome non-ATPase regulatory subunit 2 [KO:K03028]
102187906  PSMD1; 26S proteasome non-ATPase regulatory subunit 1 [KO:K03032]
102176558  PSMD3; 26S proteasome non-ATPase regulatory subunit 3 [KO:K03033]
102169405  PSMD9; 26S proteasome non-ATPase regulatory subunit 9 isoform X1 [KO:K06693]
102183635  PSMD12; 26S proteasome non-ATPase regulatory subunit 12 [KO:K03035]
102187430  PSMD11; 26S proteasome non-ATPase regulatory subunit 11 [KO:K03036]
102180165  PSMD6; 26S proteasome non-ATPase regulatory subunit 6 [KO:K03037]
102174773  PSMD7; 26S proteasome non-ATPase regulatory subunit 7 [KO:K03038]
102181192  PSMD13; 26S proteasome non-ATPase regulatory subunit 13 isoform X1 [KO:K03039]
102173623  PSMD4; 26S proteasome non-ATPase regulatory subunit 4 isoform X1 [KO:K03029]
102185511  PSMD14; 26S proteasome non-ATPase regulatory subunit 14 [KO:K03030]
102176723  PSMD8; 26S proteasome non-ATPase regulatory subunit 8 [KO:K03031]
102185667  ADRM1; proteasomal ubiquitin receptor ADRM1 [KO:K06691]
102190848  SHFM1; 26S proteasome complex subunit DSS1 [KO:K10881]
102173038  ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
102184255  TRAF2; TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
102172156  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
102182774  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
102170408  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
100861087  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
102179228  ATXN1L; ataxin-1-like [KO:K23616]
102184391  ATXN1; ataxin-1 isoform X1 [KO:K23616]
100861366  KAT5; histone acetyltransferase KAT5 isoform X1 [KO:K11304] [EC:2.3.1.48]
100861305  RORA; nuclear receptor ROR-alpha [KO:K08532]
102180626  ATP2A3; sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X1 [KO:K05853] [EC:7.2.2.10]
102187450  ATP2A1; sarcoplasmic/endoplasmic reticulum calcium ATPase 1 isoform X1 [KO:K05853] [EC:7.2.2.10]
102174960  ATP2A2; sarcoplasmic/endoplasmic reticulum calcium ATPase 2 [KO:K05853] [EC:7.2.2.10]
102186203  SLC1A6; excitatory amino acid transporter 4 isoform X1 [KO:K05617]
102177917  CIC; protein capicua homolog isoform X1 [KO:K20225]
102172215  PUM1; pumilio homolog 1 isoform X1 [KO:K17943]
102174942  PUM2; pumilio homolog 2 isoform X1 [KO:K17943]
102173392  TBPL2; TATA box-binding protein-like protein 2 [KO:K03120]
102176044  TBPL1; TATA box-binding protein-like protein 1 [KO:K03120]
102182309  TBP; TATA-box-binding protein [KO:K03120]
102186030  RBPJL; recombining binding protein suppressor of hairless-like protein isoform X1 [KO:K06053]
102185075  RBPJ; recombining binding protein suppressor of hairless isoform X3 [KO:K06053]
100860911  SP1; transcription factor Sp1 [KO:K04684]
102183029  GTF2B; transcription initiation factor IIB [KO:K03124]
102187277  NFYA; nuclear transcription factor Y subunit alpha isoform X1 [KO:K08064]
102184460  XBP1; LOW QUALITY PROTEIN: X-box-binding protein 1 [KO:K09027]
108637637  MYOD1; myoblast determination protein 1 [KO:K09064]
100860902  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
102173325  ULK1; serine/threonine-protein kinase ULK1 isoform X1 [KO:K21357] [EC:2.7.11.1]
102179415  ULK2; serine/threonine-protein kinase ULK2 isoform X1 [KO:K08269] [EC:2.7.11.1]
102185716  ATG101; autophagy-related protein 101 [KO:K19730]
102169203  ATG13; autophagy-related protein 13 isoform X1 [KO:K08331]
102180777  RB1CC1; RB1-inducible coiled-coil protein 1 [KO:K17589]
102184456  AMBRA1; activating molecule in BECN1-regulated autophagy protein 1 isoform X1 [KO:K17985]
102187882  BECN2; beclin-2 [KO:K08334]
102190728  BECN1; beclin-1 [KO:K08334]
108635484  LOW QUALITY PROTEIN: phosphoinositide 3-kinase regulatory subunit 4-like [KO:K08333] [EC:2.7.11.1]
102177934  phosphoinositide 3-kinase regulatory subunit 4 isoform X1 [KO:K08333] [EC:2.7.11.1]
102173093  ATG14; beclin 1-associated autophagy-related key regulator [KO:K17889]
108637522  nuclear receptor-binding factor 2-like isoform X1 [KO:K21246]
102177130  NRBF2; nuclear receptor-binding factor 2 isoform X1 [KO:K21246]
102171561  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 isoform X1 [KO:K00914] [EC:2.7.1.137]
102169649  ATG2A; autophagy-related protein 2 homolog A isoform X1 [KO:K17906]
102176171  ATG2B; autophagy-related protein 2 homolog B isoform X1 [KO:K17906]
102180716  WIPI2; WD repeat domain phosphoinositide-interacting protein 2 isoform X1 [KO:K17908]
102179237  WIPI1; WD repeat domain phosphoinositide-interacting protein 1 [KO:K17908]
102188248  KCNC3; potassium voltage-gated channel subfamily C member 3 isoform X1 [KO:K04889]
102175822  KCND3; potassium voltage-gated channel subfamily D member 3 isoform X1 [KO:K04893]
102172966  RELN; reelin isoform X1 [KO:K06249] [EC:3.4.21.-]
102177522  VLDLR; very low-density lipoprotein receptor isoform X1 [KO:K20053]
102169930  DAB1; disabled homolog 1 isoform X1 [KO:K20054]
102185042  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
102168391  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
102177551  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
102179343  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
102170135  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
102188710  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100860904  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
102174051  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
102187521  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
102183657  C26H10orf2; twinkle protein, mitochondrial [KO:K17680] [EC:5.6.2.3]
102177039  ATXN10; ataxin-10 [KO:K19323]
102173221  BEAN1; protein BEAN1 [KO:K19324]
102187413  NOP56; nucleolar protein 56 [KO:K14564]
Compound
C00025  L-Glutamate
C00076  Calcium cation
C00165  Diacylglycerol
C00238  Potassium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
Reference
  Authors
Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P
  Title
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
  Journal
Cerebellum 9:148-66 (2010)
DOI:10.1007/s12311-009-0144-2
Reference
  Authors
Duenas AM, Goold R, Giunti P
  Title
Molecular pathogenesis of spinocerebellar ataxias.
  Journal
Brain 129:1357-70 (2006)
DOI:10.1093/brain/awl081
Reference
  Authors
Mark MD, Schwitalla JC, Groemmke M, Herlitze S
  Title
Keeping Our Calcium in Balance to Maintain Our Balance.
  Journal
Biochem Biophys Res Commun 483:1040-1050 (2017)
DOI:10.1016/j.bbrc.2016.07.020
Reference
  Authors
Egorova PA, Bezprozvanny IB
  Title
Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
  Journal
FEBS J 285:3547-3565 (2018)
DOI:10.1111/febs.14366
Reference
  Authors
Shimobayashi E, Kapfhammer JP
  Title
Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
  Journal
Curr Neuropharmacol 16:151-159 (2018)
DOI:10.2174/1570159X15666170529104000
Reference
  Authors
Kasumu A, Bezprozvanny I
  Title
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
  Journal
Cerebellum 11:630-9 (2012)
DOI:10.1007/s12311-010-0182-9
Reference
  Authors
Egorova P, Popugaeva E, Bezprozvanny I
  Title
Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
  Journal
Semin Cell Dev Biol 40:127-33 (2015)
DOI:10.1016/j.semcdb.2015.03.010
Reference
  Authors
Hisatsune C, Hamada K, Mikoshiba K
  Title
Ca(2+) signaling and spinocerebellar ataxia.
  Journal
Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)
DOI:10.1016/j.bbamcr.2018.05.009
Reference
  Authors
Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH
  Title
Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.
  Journal
Mol Neurobiol 54:6870-6884 (2017)
DOI:10.1007/s12035-016-0205-8
Reference
  Authors
Brown SA, Loew LM
  Title
Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.
  Journal
Front Neurosci 8:453 (2014)
DOI:10.3389/fnins.2014.00453
Reference
  Authors
Inoue T
  Title
Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.
  Journal
Keio J Med 52:244-9 (2003)
DOI:10.2302/kjm.52.244
Reference
  Authors
Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N
  Title
Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.
  Journal
J Biol Chem 283:19854-63 (2008)
DOI:10.1074/jbc.M801492200
Reference
  Authors
Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS
  Title
Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
  Journal
Brain 138:2537-52 (2015)
DOI:10.1093/brain/awv195
Reference
  Authors
Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F
  Title
Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
  Journal
J Med Genet 56:499-511 (2019)
DOI:10.1136/jmedgenet-2018-105766
Reference
  Authors
Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F
  Title
Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
  Journal
Neurobiol Dis 124:14-28 (2019)
DOI:10.1016/j.nbd.2018.10.018
Reference
  Authors
Becker EBE
  Title
From Mice to Men: TRPC3 in Cerebellar Ataxia.
  Journal
Cerebellum 16:877-879 (2017)
DOI:10.1007/s12311-015-0663-y
Reference
  Authors
Hoxha E, Tempia F, Lippiello P, Miniaci MC
  Title
Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.
  Journal
Front Synaptic Neurosci 8:35 (2016)
DOI:10.3389/fnsyn.2016.00035
Reference
  Authors
Yan H, Pablo JL, Pitt GS
  Title
FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
  Journal
Cell Rep 4:66-75 (2013)
DOI:10.1016/j.celrep.2013.06.012
Reference
  Authors
Tada M, Nishizawa M, Onodera O
  Title
Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.
  Journal
Neurochem Int 94:1-8 (2016)
DOI:10.1016/j.neuint.2016.01.007
Reference
  Authors
Pietrobon D
  Title
CaV2.1 channelopathies.
  Journal
Pflugers Arch 460:375-93 (2010)
DOI:10.1007/s00424-010-0802-8
Reference
  Authors
Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T
  Title
Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
  Journal
Neurobiol Dis 17:198-204 (2004)
DOI:10.1016/j.nbd.2004.07.013
Reference
  Authors
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H
  Title
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.
  Journal
Genes Dev 16:1345-55 (2002)
DOI:10.1101/gad.992302
Reference
  Authors
Evers MM, Toonen LJ, van Roon-Mom WM
  Title
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
  Journal
Mol Neurobiol 49:1513-31 (2014)
DOI:10.1007/s12035-013-8596-2
Reference
  Authors
Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC
  Title
Polyglutamine tracts regulate autophagy.
  Journal
Autophagy 13:1613-1614 (2017)
DOI:10.1080/15548627.2017.1336278
Reference
  Authors
Chen RH, Chen YH, Huang TY
  Title
Ubiquitin-mediated regulation of autophagy.
  Journal
J Biomed Sci 26:80 (2019)
DOI:10.1186/s12929-019-0569-y
Reference
  Authors
Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT
  Title
RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  Journal
Cell 127:697-708 (2006)
DOI:10.1016/j.cell.2006.09.036
Reference
  Authors
Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT
  Title
ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
  Journal
Neuron 97:1235-1243.e5 (2018)
DOI:10.1016/j.neuron.2018.02.013
Reference
  Authors
Jimenez G, Shvartsman SY, Paroush Z
  Title
The Capicua repressor--a general sensor of RTK signaling in development and disease.
  Journal
J Cell Sci 125:1383-91 (2012)
DOI:10.1242/jcs.092965
Reference
  Authors
Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY
  Title
A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.
  Journal
Cell 172:924-936.e11 (2018)
DOI:10.1016/j.cell.2018.02.006
Reference
  Authors
Irie T, Matsuzaki Y, Sekino Y, Hirai H
  Title
Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
  Journal
J Physiol 592:229-47 (2014)
DOI:10.1113/jphysiol.2013.264309
Reference
  Authors
Bushart DD, Murphy GG, Shakkottai VG
  Title
Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
  Journal
Ann Transl Med 4:25 (2016)
DOI:10.3978/j.issn.2305-5839.2016.01.06
Reference
  Authors
Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ
  Title
Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.
  Journal
Hum Mutat 40:2088-2107 (2019)
DOI:10.1002/humu.23865
Reference
  Authors
Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS
  Title
Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
  Journal
Cell Mol Life Sci 72:3387-99 (2015)
DOI:10.1007/s00018-015-1894-2
Reference
  Authors
Matilla-Duenas A, Volpini V
  Title
Spinocerebellar Ataxia Type 37
  Journal
GeneReviews (1993)
Reference
  Authors
Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A
  Title
Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
  Journal
Brain 141:1981-1997 (2018)
DOI:10.1093/brain/awy137
Reference
  Authors
Swinnen B, Robberecht W, Van Den Bosch L
  Title
RNA toxicity in non-coding repeat expansion disorders.
  Journal
EMBO J e101112 (2019)
DOI:10.15252/embj.2018101112
Reference
  Authors
Ishikawa K, Nagai Y
  Title
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).
  Journal
Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)
DOI:10.1007/s13311-019-00804-6
Reference
  Authors
Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K
  Title
Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.
  Journal
Neuropathology 33:600-11 (2013)
DOI:10.1111/neup.12032
Reference
  Authors
Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, Habu T, Liu W, Okuda H, Koizumi A
  Title
Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
  Journal
Am J Hum Genet 89:121-30 (2011)
DOI:10.1016/j.ajhg.2011.05.015
Related
pathway
chx03050  Proteasome
chx04020  Calcium signaling pathway
chx04140  Autophagy - animal
chx04141  Protein processing in endoplasmic reticulum
chx04210  Apoptosis
chx04724  Glutamatergic synapse
chx04730  Long-term depression
KO pathway
ko05017   
LinkDB

DBGET integrated database retrieval system